ADC Therapeutics S.A.
ADCT | NYSE
$1.19
+$0.07 (+6.25%)
Sep 22, 2026, 10:51 AM ET · Market open
Fiscal Quarter Period Ending | Q2 2026 Jun 29, 2026 | Q1 2026 Mar 30, 2026 | Q4 2025 Dec 30, 2025 | Q3 2025 Sep 29, 2025 | Q2 2025 Jun 29, 2025 | Q1 2025 Mar 30, 2025 | Q4 2024 Dec 30, 2024 | Q3 2024 Sep 29, 2024 | Q2 2024 Jun 29, 2024 | Q1 2024 Mar 30, 2024 | Q4 2023 Dec 30, 2023 | Q3 2023 Sep 29, 2023 | Q2 2023 Jun 29, 2023 | Q1 2023 Mar 30, 2023 | Q4 2022 Dec 30, 2022 | Q3 2022 Sep 29, 2022 | Q2 2022 Jun 29, 2022 | Q1 2022 Mar 30, 2022 | Q4 2021 Dec 30, 2021 | Q3 2021 Sep 29, 2021 | Q2 2021 Jun 29, 2021 | Q1 2021 Mar 30, 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | 19.25M | 20.03M | 23.06M | 16.43M | 18.84M | 23.03M | 16.91M | 18.46M | 17.41M | 18.05M | 16.79M | 14.49M | 19.28M | 18.99M | 69.8M | 76.32M | 17.29M | 46.5M | 17.01M | 13.15M | 3.76M | n/a |
Cost of Revenue | 2.35M | 3.62M | 1.7M | 1.2M | 836K | 2.06M | 1.37M | 851K | 1.22M | 2.51M | 125.15M | 366K | 1.13M | -27K | 489K | 1.3M | 2.27M | 529K | 770K | 502K | 121K | n/a |
Gross Profit | 16.9M | 16.42M | 21.36M | 15.23M | 18M | 20.97M | 15.54M | 17.61M | 16.19M | 15.54M | -108.36M | 14.13M | 18.15M | 19.02M | 69.31M | 75.03M | 15.03M | 45.97M | 16.24M | 12.65M | 3.64M | n/a |
Operating Income | -25.41M | -25.25M | -18.12M | -30.33M | -44.15M | -28.46M | -32.44M | -35.56M | -29.04M | -33.61M | -39.98M | -37.4M | -39.65M | -50.21M | -10.74M | -3.11M | -69.41M | -40.36M | -62.78M | -57.79M | -70.48M | -70.67M |
Interest Income | 1.82M | 1.99M | 2.35M | 2.47M | 1.93M | 2.05M | 2.63M | 3.44M | 3.25M | 2.95M | 3.29M | 3.14M | 2.37M | 2.18M | 1.63M | 273K | 16K | 18.31M | 20K | 16K | 15K | 15K |
Pretax Income | -16.57M | -32.97M | -6.81M | -40.97M | -55.39M | -38.44M | -31.05M | -43.88M | -36.31M | -46.44M | -41.86M | -47.89M | -53.42M | -58.86M | -20.19M | -51.32M | -65.32M | -17.83M | -56.35M | -71.4M | -72.33M | -51.42M |
Net Income | -16.57M | -32.97M | -6.41M | -40.97M | -56.65M | -38.6M | -30.73M | -43.97M | -36.54M | -46.61M | -85.03M | -47.81M | -48.92M | -59.37M | -24.16M | -50.61M | -64.37M | -16.66M | -34.38M | -71.55M | -72.57M | -51.53M |
Selling & General & Admin | 22.27M | 22.6M | 21.44M | 19.01M | 18.97M | -598K | 20.87M | 20.68M | 20.94M | 23.42M | 25.22M | 23.09M | 26.46M | 30.85M | 31.31M | 36.46M | 30.02M | 37.38M | 36.53M | 33.63M | 34.59M | 31.49M |
Research & Development | 17.37M | 19.88M | 18.18M | 26.8M | 30.09M | 28.93M | 27.1M | 32.5M | 24.3M | 25.74M | 30.33M | 28.44M | 31.34M | 38.38M | 48.73M | 41.68M | 48.54M | 48.95M | 42.49M | 36.81M | 39.53M | 39.17M |
Other Expenses | 2.67M | -818K | -144K | -266K | 13.09M | 21.11M | n/a | n/a | n/a | n/a | -123.93M | n/a | n/a | n/a | n/a | n/a | 5.88M | n/a | n/a | n/a | n/a | n/a |
Operating Expenses | 42.31M | 41.66M | 39.48M | 45.55M | 62.15M | 49.44M | 47.98M | 53.18M | 45.23M | 49.16M | -68.38M | 51.53M | 57.8M | 69.23M | 80.05M | 78.14M | 84.44M | 86.33M | 79.02M | 70.44M | 74.12M | 70.67M |
Interest Expense | 13.51M | 12.35M | 13.01M | 13.39M | 13M | 12.23M | 11.92M | 13.12M | 12.68M | 12.5M | 7.68M | 12.94M | 10.31M | 10.29M | 9.8M | 11.36M | 8.8M | 9.22M | 9.52M | 4.27M | 2.56M | 2M |
Selling & Marketing Expenses | 12.57M | 12.71M | 5.85M | 5M | 4.01M | -10.55M | 5.72M | 5.06M | 4.85M | 5.81M | 13.93M | 8.04M | 8.33M | 7.28M | 16.18M | 8.24M | 9.26M | 18.37M | 64.78M | 17.05M | 15.22M | 13.91M |
Cost & Expenses | 44.66M | 45.28M | 41.18M | 46.75M | 62.99M | 51.5M | 49.35M | 54.03M | 46.45M | 51.67M | 56.77M | 51.9M | 58.93M | 69.2M | 80.54M | 79.44M | 86.7M | 86.86M | 79.79M | 70.94M | 74.24M | 70.67M |
Income Tax Expense | n/a | n/a | -404K | n/a | 1.25M | 165K | -321K | 90K | 234K | 163K | 43.17M | -86K | -4.5M | 518K | 3.97M | -711K | -947K | -1.17M | -21.97M | 145K | 240K | 107K |
Shares Outstanding (Basic) | 155.02M | 154.14M | 150.3M | 136.45M | 113.74M | 107.2M | 105.4M | 104.82M | 95.69M | 82.55M | 82.29M | 82.26M | 81.47M | 80.81M | 80.64M | 78.37M | 76.91M | 76.82M | 76.4M | 76.74M | 76.73M | 76.72M |
Shares Outstanding (Diluted) | 155.02M | 154.14M | 150.3M | 136.45M | 113.74M | 107.2M | 105.4M | 104.82M | 95.69M | 82.55M | 82.29M | 82.26M | 81.47M | 80.81M | 80.64M | 78.37M | 76.91M | 76.82M | 76.4M | 76.74M | 76.73M | 76.72M |
EPS (Basic) | -0.11 | -0.21 | -0.04 | -0.30 | -0.50 | -0.36 | -0.29 | -0.42 | -0.38 | -0.56 | -1.03 | -0.58 | -0.58 | -0.73 | -0.30 | -0.65 | -0.84 | -0.22 | -0.45 | -0.93 | -0.95 | -0.67 |
EPS (Diluted) | -0.11 | -0.21 | -0.04 | -0.30 | -0.50 | -0.36 | -0.29 | -0.42 | -0.38 | -0.56 | -1.03 | -0.58 | -0.58 | -0.73 | -0.30 | -0.65 | -0.84 | -0.22 | -0.45 | -0.93 | -0.95 | -0.67 |
EBITDA | -45.95M | -20.39M | 6.31M | -27.45M | -41.56M | -25.69M | -18.83M | -29.7M | -22.2M | -32.42M | -33.85M | -32.99M | -41.53M | -46.48M | -12.06M | -39.39M | -55.93M | -8.02M | -46.07M | -64.27M | -69.14M | -48.84M |
EBIT | -45.95M | -20.62M | 6.2M | -27.57M | -42.4M | -26.49M | -19.63M | -30.5M | -23.03M | -33.26M | -34.19M | -33.79M | -42.34M | -47.2M | -12.64M | -39.96M | -56.52M | -8.61M | -46.83M | -64.93M | -69.77M | -49.42M |
Depreciation & Amortization | n/a | 225K | 113K | 122K | 840K | 801K | 793K | 802K | 838K | 843K | 335K | 793K | 812K | 723K | 576K | 572K | 586K | 594K | 759K | 658K | 635K | 578K |
Add to Watchlist
Select watchlists to add or remove ADCT